Zelboraf Logo
Nov. 15, 2024
Genentech: Zelboraf® (vemurafenib) - Information for Healthcare Providers Zelboraf Cotellic Vemurafenib (Zelboraf) + Cobimetinib (Cotellic) Melanoma Zelboraf doubles survival time of skin cancer patients | Healthcare Digital Cotellic® | Home COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Dose Modification for HCPs FDA Approves Roche Skin Cancer Drug Zelboraf | Zelboraf Logo